41.12
price up icon0.98%   0.40
after-market 시간 외 거래: 41.16 0.04 +0.10%
loading
전일 마감가:
$40.72
열려 있는:
$40.78
하루 거래량:
1.70M
Relative Volume:
1.32
시가총액:
$3.90B
수익:
$47.30M
순이익/손실:
$-225.97M
주가수익비율:
-17.50
EPS:
-2.35
순현금흐름:
$-188.86M
1주 성능:
+6.56%
1개월 성능:
+20.80%
6개월 성능:
-8.38%
1년 성능:
+372.10%
1일 변동 폭
Value
$40.22
$41.60
1주일 범위
Value
$38.41
$43.97
52주 변동 폭
Value
$6.76
$46.98

Scholar Rock Holding Corp Stock (SRRK) Company Profile

Name
명칭
Scholar Rock Holding Corp
Name
전화
857-259-3860
Name
주소
301 BINNEY STREET, CAMBRIDGE, MA
Name
직원
196
Name
트위터
@ScholarRock
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
SRRK's Discussions on Twitter

SRRK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SRRK
Scholar Rock Holding Corp
41.12 3.66B 47.30M -225.97M -188.86M -2.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-17 개시 Cantor Fitzgerald Overweight
2024-11-26 재확인 H.C. Wainwright Buy
2024-10-07 재확인 H.C. Wainwright Buy
2024-03-28 개시 Raymond James Strong Buy
2023-10-25 업그레이드 Jefferies Hold → Buy
2023-04-03 재개 Piper Sandler Overweight
2022-09-19 재개 H.C. Wainwright Buy
2022-07-12 개시 Truist Buy
2022-03-23 개시 H.C. Wainwright Buy
2021-12-22 다운그레이드 Jefferies Buy → Hold
2021-11-19 개시 Piper Sandler Overweight
2021-04-26 재개 Credit Suisse Outperform
2021-01-11 개시 Credit Suisse Outperform
2021-01-06 개시 JP Morgan Overweight
2020-03-12 개시 Robert W. Baird Outperform
모두보기

Scholar Rock Holding Corp 주식(SRRK)의 최신 뉴스

pulisher
08:01 AM

Scholar Rock Earnings Preview: SMA Drug Developer Sets Q2 Results Date, Key Updates Expected - Stock Titan

08:01 AM
pulisher
08:00 AM

Scholar Rock to Host Conference Call to Discuss Second Quarter 2025 Financial Results and Provide Business Update on August 6, 2025 - FinancialContent

08:00 AM
pulisher
02:03 AM

Cantor Fitzgerald Forecasts Scholar Rock FY2025 Earnings - Defense World

02:03 AM
pulisher
Jul 20, 2025

Scholar Rock (NASDAQ:SRRK) Now Covered by Cantor Fitzgerald - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Scholar Rock (NASDAQ:SRRK) Research Coverage Started at Cantor Fitzgerald - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

Insider Selling: Scholar Rock Holding Corporation (NASDAQ:SRRK) Director Sells 11,136 Shares of Stock - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

M&T Bank Corp Sells 489 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Scholar Rock Holding Corporation Stock Analysis and ForecastSuperior trading gains - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Scholar Rock Holding Corporation stock priceSuperior returns - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Will CVR Energy Inc. stock benefit from AI tech trendsFree Access to Community with 300% Return - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Use AI to optimize your outbound sales efforts by targeting the right prospectsFree Premium Stock Market Reports - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Scholar Rock Holding (SRRK) Gains Analyst Support with New Cover - GuruFocus

Jul 17, 2025
pulisher
Jul 16, 2025

Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives $42.67 Average PT from Brokerages - MarketBeat

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Scholar Rock Holding Corporation stock price move sharplyFree AI-Powered Stock Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Scholar Rock Holding Corporation stock performs during market volatilityCapital Preservation Investment Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Scholar Rock Holding Corporation stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Alarum Technologies Ltd. Depositary Receipt stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Scholar Rock (NASDAQ:SRRK) Trading Up 6.5%What's Next? - MarketBeat

Jul 13, 2025
pulisher
Jul 11, 2025

Scholar Rock CSO Mo Qatanani sells $828,898 in shares By Investing.com - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 11, 2025

High Growth Tech Stocks To Watch In US July 2025 - Yahoo Finance

Jul 11, 2025
pulisher
Jul 11, 2025

Scholar Rock CSO Mo Qatanani sells $828,898 in shares - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

Insider Sell: Mo Qatanani Sells 24,066 Shares of Scholar Rock Ho - GuruFocus

Jul 11, 2025
pulisher
Jul 03, 2025

Scholar Rock Q1 2025 slides: apitegromab advances toward FDA approval with priority review - Investing.com Nigeria

Jul 03, 2025
pulisher
Jun 30, 2025

Scholar Rock Holding Corporation(NasdaqGS:SRRK) dropped from Russell 3000E Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

Scholar Rock (NASDAQ:SRRK) Trading Up 5.2%Here's What Happened - MarketBeat

Jun 28, 2025
pulisher
Jun 26, 2025

Truist reiterates buy rating on Scholar Rock stock amid SMA therapy potential - Investing.com Nigeria

Jun 26, 2025
pulisher
Jun 25, 2025

Is Scholar Rock Holding Corp. overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

Scholar Rock CEO on its drug that could preserve muscle in weight-loss drug users - CNBC

Jun 24, 2025
pulisher
Jun 23, 2025

Syncona restructures biotech fund; Lilly’s $1B Verve bet; FDA’s two-track future — a BioCentury podcast - biocentury.com

Jun 23, 2025
pulisher
Jun 23, 2025

Scholar Rock's Breakthrough SMA Drug Shows Positive Phase 3 Results, FDA Fast-Tracks Review - Stock Titan

Jun 23, 2025
pulisher
Jun 22, 2025

Scholar Rock (NASDAQ:SRRK) Trading Down 5.7% – Time to Sell? - Defense World

Jun 22, 2025
pulisher
Jun 21, 2025

Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 21, 2025
pulisher
Jun 20, 2025

SG Americas Securities LLC Increases Position in Scholar Rock Holding Corporation (NASDAQ:SRRK) - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial - Yahoo Finance

Jun 19, 2025
pulisher
Jun 18, 2025

Scholar Rock (NASDAQ:SRRK) Receives Outperform Rating from Wedbush - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Why Scholar Rock Shares Are Soaring Today - The Globe and Mail

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock (NASDAQ:SRRK) Shares Gap UpWhat's Next? - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Transcript : Scholar Rock Holding CorporationSpecial Call - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock's Atrophy Drug When Combined With Eli Lilly's Zepbound Shows Around 55% Better Muscle Preservation In Weight Loss Study - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock stock soars after drug shows promise in preserving lean mass during weight loss - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

Trading Day Triumph: Scholar Rock Holding Corp (SRRK) Ends at 31.15, a -3.05 Surge/Plunge - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock's drug helps Zepbound patients retain more muscle in trial - marketscreener.com

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock (SRRK) Surges 14% Following EMBRAZE Trial Results | SRRK Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock (SRRK) Surges After Promising Weight Loss Trial - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock Reports Positive Results From Phase 2 EMBRAZE Study - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

Scholar Rock stock gains on weight loss data (SRRK:NASDAQ) - Seeking Alpha

Jun 18, 2025

Scholar Rock Holding Corp (SRRK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):